Altogether, we demonstrate for the first time, a global proteomic signature for cancer stem cell enriched letrozole resistant mammospheres that is associated with high midasin expression, increased components of the translational machinery, and finally, that increased midasin expression is associated with decreased RFS in ER- breast cancer patients. The gene discussed is MDN1; the disease is breast carcinoma.